Baldán Á - Search Results

1

Anti-miR-33 therapy does not alter the progression of atherosclerosis in low-density lipoprotein receptor-deficient mice.

Marquart TJ, Wu J, Lusis AJ, Baldán Á. Marquart TJ, et al. Among authors: baldan a. Arterioscler Thromb Vasc Biol. 2013 Mar;33(3):455-8. doi: 10.1161/ATVBAHA.112.300639. Epub 2013 Jan 3. Arterioscler Thromb Vasc Biol. 2013. PMID: 23288159 Free PMC article.

2

Impaired development of atherosclerosis in hyperlipidemic Ldlr-/- and ApoE-/- mice transplanted with Abcg1-/- bone marrow.

Baldán A, Pei L, Lee R, Tarr P, Tangirala RK, Weinstein MM, Frank J, Li AC, Tontonoz P, Edwards PA. Baldán A, et al. Arterioscler Thromb Vasc Biol. 2006 Oct;26(10):2301-7. doi: 10.1161/01.ATV.0000240051.22944.dc. Epub 2006 Aug 3. Arterioscler Thromb Vasc Biol. 2006. PMID: 16888235

3

miR-33 links SREBP-2 induction to repression of sterol transporters.

Marquart TJ, Allen RM, Ory DS, Baldán A. Marquart TJ, et al. Among authors: baldan a. Proc Natl Acad Sci U S A. 2010 Jul 6;107(27):12228-32. doi: 10.1073/pnas.1005191107. Epub 2010 Jun 21. Proc Natl Acad Sci U S A. 2010. PMID: 20566875 Free PMC article.

4

miR-33 controls the expression of biliary transporters, and mediates statin- and diet-induced hepatotoxicity.

Allen RM, Marquart TJ, Albert CJ, Suchy FJ, Wang DQ, Ananthanarayanan M, Ford DA, Baldán A. Allen RM, et al. Among authors: baldan a. EMBO Mol Med. 2012 Sep;4(9):882-95. doi: 10.1002/emmm.201201228. Epub 2012 Jul 5. EMBO Mol Med. 2012. PMID: 22767443 Free PMC article.

5

Quest for new biomarkers in atherosclerosis.

Cho Y, Baldán A. Cho Y, et al. Among authors: baldan a. Mo Med. 2013 Jul-Aug;110(4):325-30. Mo Med. 2013. PMID: 24003651 Free PMC article.

6

Control of very low-density lipoprotein secretion by N-ethylmaleimide-sensitive factor and miR-33.

Allen RM, Marquart TJ, Jesse JJ, Baldán A. Allen RM, et al. Among authors: baldan a. Circ Res. 2014 Jun 20;115(1):10-22. doi: 10.1161/CIRCRESAHA.115.303100. Epub 2014 Apr 21. Circ Res. 2014. PMID: 24753547 Free PMC article.

7

Perilipin-5 is regulated by statins and controls triglyceride contents in the hepatocyte.

Langhi C, Marquart TJ, Allen RM, Baldán A. Langhi C, et al. Among authors: baldan a. J Hepatol. 2014 Aug;61(2):358-65. doi: 10.1016/j.jhep.2014.04.009. Epub 2014 Apr 21. J Hepatol. 2014. PMID: 24768901 Free PMC article.

8

Long-term therapeutic silencing of miR-33 increases circulating triglyceride levels and hepatic lipid accumulation in mice.

Goedeke L, Salerno A, Ramírez CM, Guo L, Allen RM, Yin X, Langley SR, Esau C, Wanschel A, Fisher EA, Suárez Y, Baldán A, Mayr M, Fernández-Hernando C. Goedeke L, et al. Among authors: baldan a. EMBO Mol Med. 2014 Sep;6(9):1133-41. doi: 10.15252/emmm.201404046. EMBO Mol Med. 2014. PMID: 25038053 Free PMC article.

9

ABCG1 is required for pulmonary B-1 B cell and natural antibody homeostasis.

Baldan A, Gonen A, Choung C, Que X, Marquart TJ, Hernandez I, Bjorkhem I, Ford DA, Witztum JL, Tarling EJ. Baldan A, et al. J Immunol. 2014 Dec 1;193(11):5637-48. doi: 10.4049/jimmunol.1400606. Epub 2014 Oct 22. J Immunol. 2014. PMID: 25339664 Free PMC article.

10

miR-27b inhibits LDLR and ABCA1 expression but does not influence plasma and hepatic lipid levels in mice.

Goedeke L, Rotllan N, Ramírez CM, Aranda JF, Canfrán-Duque A, Araldi E, Fernández-Hernando A, Langhi C, de Cabo R, Baldán Á, Suárez Y, Fernández-Hernando C. Goedeke L, et al. Among authors: baldan a. Atherosclerosis. 2015 Dec;243(2):499-509. doi: 10.1016/j.atherosclerosis.2015.09.033. Atherosclerosis. 2015. PMID: 26520906 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

100 results

Search Page

Filters